Drug Profile
Budesonide inhalation - AstraZeneca
Alternative Names: Rhinocort; Rhinocort AquaLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator AstraZeneca
- Developer AstraZeneca; Cilag GmbH International
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Nasal polyps; Perennial allergic rhinitis; Rhinitis; Seasonal allergic rhinitis